231 Amorphous and Crystalline Particle Engineering in Pharmaceuticals and Other Novel Materials


Description:
The focus of this session will be on the engineering of amorphous and crystalline particles, using modelling as well as solution based processes and particle engineering techniques. An added focus of the session is the utilization of these techniques towards the crystallization of novel materials across industries, such as zeolites, metal organic frameworks, inorganic or organic semiconductors, proteins or peptides and new small molecule compounds.

Sponsor:
Crystallization and Evaporation
Co-Sponsor(s):
Materials Engineering and Sciences Division (08), Particle Technology Forum (03)


Chair:

Lotfi Derdour
Material Science. Chemical Development, Glaxosmithkline, Collegeville, PA
Co-chairs:

Mo Jiang
Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA

Ryan Snyder
Chemical Engineering, Bucknell University, Lewisburg, PA

Abstract Submissions Closed
See more of this Group/Topical: Separations Division